KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aehr Test Systems (AEHR) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Aehr Test Systems (AEHR) over the last 15 years, with Q4 2025 value amounting to $467000.0.

  • Aehr Test Systems' Capital Expenditures rose 4548.29% to $467000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $6.3 million, marking a year-over-year increase of 66565.9%. This contributed to the annual value of $5.0 million for FY2025, which is 56648.87% up from last year.
  • Per Aehr Test Systems' latest filing, its Capital Expenditures stood at $467000.0 for Q4 2025, which was up 4548.29% from $1.4 million recorded in Q3 2025.
  • In the past 5 years, Aehr Test Systems' Capital Expenditures registered a high of $2.8 million during Q2 2025, and its lowest value of $11000.0 during Q1 2021.
  • Its 5-year average for Capital Expenditures is $470500.0, with a median of $176500.0 in 2023.
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 9611.49% in 2024, then surged by 602608.7% in 2025.
  • Aehr Test Systems' Capital Expenditures (Quarter) stood at $73000.0 in 2021, then plummeted by 79.45% to $15000.0 in 2022, then soared by 940.0% to $156000.0 in 2023, then surged by 105.77% to $321000.0 in 2024, then soared by 45.48% to $467000.0 in 2025.
  • Its Capital Expenditures stands at $467000.0 for Q4 2025, versus $1.4 million for Q3 2025 and $2.8 million for Q2 2025.